Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia

Completed · Phase 1/Phase 2

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.

Key facts

Study ID

NCT00080184

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

40

Starts

2003-12-01

Expected to finish

2006-05-01

Last updated by the study team

2006-08-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of fibromyalgia with symptoms for at least 1 year
• Self-report of having attention/concentration, memory, multi-tasking or other thinking difficulties
• Able to read and understand English
• Able to attend treatment sessions weekly and return for planned follow-ups
• Appropriate balance of average delta (<4 Hertz) EEG waveband and alpha (approximately 4-8 Hertz) EEG waveband amplitude on LENS screening (to be determined by study personnel);

You may not qualify if…

• Other chronic pain condition of major significance
• Current chronic viral infection
• Current other unstable medical condition
• History of spinal, including neck, surgery
• Psychological screening indicates psychotic, suicidal, homicidal, and/or substance abusing
• Use of long-acting opioid medication taken on a continuous 24-hour dosing schedule
• Current involved in litigation regarding pain condition or seeking disability
• History of electroconvulsive therapy

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.